No information is available on the clinical use of spinosad during breastfeeding. Because it is not systemically absorbed after topical application, it should not be present in breastmilk. However, the topical suspension contains benzyl alcohol, which may be systemically absorbed through the skin. High doses of benzyl alcohol are potentially toxic to neonates, but it is unlikely that doses this high reach breastmilk.[1] Any product applied to the breast should be removed from the breast with soap and water before breastfeeding to avoid direct infant exposure.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Fernando DD, Fischer K. Spinosad topical suspension (0.9%): A new topical treatment for scabies. Expert Rev Anti Infect Ther 2022;20:1149-54. [PubMed: 35799317]
Substance Identification
Substance Name
Spinosad
CAS Registry Number
168316-95-8
Drug Class
Breast Feeding
Lactation
Milk, Human
Insecticides
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
